Market Access News | pharmaphorum

News

Patients resist Novo Nordisk plan to stop making Levemir

A patient advocacy group has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir, arguing that it could leave some diabetics with

News

Vertex eyes FDA decision on non-opioid pain drug in January

Vertex Pharma has filed for FDA approval of its non-opioid pain drug suzetrigine, starting the clock ticking on a review that should be completed early next year.

News

Image of the word No in gold neon lights

NICE blocks Enhertu use after pricing talks break down

NICE and drugmakers AstraZeneca and Daiichi Sankyo have all expressed their disappointment at being unable to agree on a price for Enhertu that would allow it to be used on the NHS for peop

News

Ipsen's Alagille drug backed by CHMP again, with new name

In unusual circumstances, Ipsen has been given the green light for its odevixibat drug for severe itching (pruritus) in patients with rare liver disease Alagille syndrome (ALGS) in the EU –

News

physician holds hand of a person with chronic hand eczema

LEO closes on first approval for chronic hand eczema drug

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

News

In shock move, EU panel rejects Alzheimer's drug Leqembi

The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China, and Japan gave a green lig

Patients resist Novo Nordisk plan to stop making Levemir

Vertex eyes FDA decision on non-opioid pain drug in January

NICE blocks Enhertu use after pricing talks break down

Ipsen's Alagille drug backed by CHMP again, with new name

LEO closes on first approval for chronic hand eczema drug

In shock move, EU panel rejects Alzheimer's drug Leqembi

Inept digital interaction undermining pharma with clinicians

How to meet your physicians where they are online

News

Editor's Picks